ESHRE 2025 - Main programme


Please take the 
time zone differences into account! Times are shown in CE(S)T – Central European (Summer) Time.
>> Monday >> Tuesday >> Wednesday


Monday 30 June 2025

08:30 - 09:30
Invited session 01: Keynote session
08:30 - 09:00
HR Keynote lecture
Speaker to be announced
09:00 - 09:30
Detecting scientific fraud
Jennifer Byrne, Australia

09:30 - 10:00
Coffee break

10:00 - 11:30
6 Parallel Selected oral communications sessions

10:00 - 11:30
Poster discussion session

11:45 - 13:00
Industry sponsored symposium

11:45 - 12:45
Invited session 02: Debate: Should we transfer embryos derived from 0PN-1PN-3PN
11:45 - 12:00
Yes
Cristina Magli, Italy
12:00 - 12:15
No
Ioannis Sfontouris, Greece
12:15 - 12:20
Rebuttal
Cristina Magli, Italy
12:20 - 12:25
Rebuttal
Ioannis Sfontouris, Greece
12:25 - 12:45
Discussion

11:45 - 12:45
Invited session 03: Data reporting session

11:45 - 12:45
Invited session 04: Exchange session

11:45 - 12:45
Invited session 05: Managing weight and nurturing life
11:45 - 12:05
The impact of obesity on reproduction from menarche to menopause
Fionnuala M McAuliffe, Ireland
12:05 - 12:15
Discussion
12:15 - 12:35
Obesity, implantation and early pregnancy - does GLP1 play a role?
Speaker to be announced
12:35 - 12:45
Discussion

11:45 - 12:45
Invited session 06: Live journal club

11:45 - 12:45
Poster discussion session

13:00 - 14:00
Lunch break

14:00 - 15:15
Industry sponsored symposium

14:00 - 15:00
Invited session 07: Whole genome sequencing of human embryos: technical challanges and ethical dilemmas
14:00 - 14:20
Analytical capability and clinical utility of WGS in PGT
Olga Tšuiko, Belgium
14:20 - 14:30
Discussion
14:30 - 14:50
Ethical and counseling considerations
Speaker to be announced
14:50 - 15:00
Discussion

14:00 - 15:00
Invited session 08: Debate: IVF planning in poor prognosis patients - cycle to cycle approach or multicycle approach is best?
14:00 - 14:15
Cycle to cycle approach is best!
Christos Venetis, Greece
14:15 - 14:30
Multicycle approach is a valid option in poor prognosis patients?
Alberto Vaiarelli, Italy
14:30 - 14:35
Rebuttal
Christos Venetis, Greece
14:35 - 14:40
Rebuttal
Alberto Vaiarelli, Italy
14:40 - 15:00
Discussion

14:00 - 15:00
Invited session 09: Exchange session

14:00 - 15:00
Selected oral communications session

14:00 - 15:00
Invited session 10: Exchange session

14:00 - 15:00
Poster discussion session

15:15 - 16:30
6 Parallel Selected oral communications sessions

15:15 - 16:30
Poster discussion session

16:30 - 17:00
Coffee break

17:00 - 18:15
Industry sponsored session

17:00 - 18:00
Invited session 11: Diagnostics/screening tests for endometriosis
17:00 - 17:20
Imaging for endometriosis: from the past to the future
Mee Kristine Aas-Eng, Norway
17:20 - 17:30
Discussion
17:30 - 17:50
Beyond imaging: are we there yet?
Arne Vanhie, Belgium
17:50 - 18:00
Discussion

17:00 - 18:00
Invited session 12: Male infertility and comorbidities - what do we know?
17:00 - 17:20
What we know from big cohort studies
Michael Eisenberg, U.S.A.
17:20 - 17:30
Discussion
17:30 - 17:50
What we know of putative causal relations
Maria Schubert, Germany
17:50 - 18:00
Discussion

17:00 - 18:00
Invited session 13: Innovations in vitro gametogenesis and gonadogenesis
17:00 - 17:20
Pioneering in vitro gametogenesis
Speaker to be announced
17:20 - 17:30
Discussion
17:30 - 17:50
Pluripotent models for gonadal research
Anna Biason-Lauber, Switzerland
17:50 - 18:00
Discussion

17:00 - 18:00
Selected oral communications

17:00 - 18:00
Invited session 14: Guidelines session

17:00 - 18:00
Poster discussion session